PALISADE BIO, INC. Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31)
PALISADE BIO, INC. (PALI) had Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) of 11.00% as of 2013-12-31, per its 10-Q filed 2014-05-12.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentInterestRateAtPeriodEnd · last filed 2014-05-12
- 2013-12-31: Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) 11.00%.
- 2013-09-30: Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) 11.00%.
- 2013-06-30: Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) 11.00%.
- 2013-03-31: Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) 11.00%.
| Period end | Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) |
|---|---|
| 2013-12-31 | 11.00% 10-Q · filed 2014-05-12 |
| 2013-09-30 | 11.00% 10-Q · filed 2013-11-12 |
| 2013-06-30 | 11.00% 10-Q · filed 2013-08-08 |
| 2013-03-31 | 11.00% 10-Q · filed 2013-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |